VATS Versus Thoracotomy for Pulmonary Hydatid Disease

Pulmonary Hydatid Cyst Clinical Trial

— VATS  

Official title:

VATS Versus Thoracotomy for Pulmonary Hydatid Disease

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04412512
• Other study ID #: VATS for pulmonary hydatid
• Status: Completed
• Phase: N/A
• Start date: January 2016
• Est. completion date: April 2020

Study information

• Verified date: May 2020
• Source: Hassan II University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to evaluate the efficacy and safety of minimally invasive surgery and compare the outcomes with patients undergoing thoracotomy in treatment of Pulmonary Hydatid Cyst.

Disease : pulmonary hydatid cyst.

Intervention:

• Group 1 : VATS approach.

• Group 2 : thoracotomy approach.

Description:

After being informed about the study and the approach, all patients giving written informed consent to determine eligibility for study entry.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 134
• Est. completion date: April 2020
• Est. primary completion date: December 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 6 Years to 81 Years

Eligibility

Inclusion Criteria:

• all patients underwent surgery for pulmonary hydatid cyst

Exclusion Criteria:

• none

Related Conditions & MeSH terms

• Pulmonary Hydatid Cyst

Intervention

Procedure:
• VATS approach
video-assisted thoracic surgery approach
• Thoracotomy approach

Locations

Country	Name	City	State
Morocco	Hassan II University	Casablanca

Sponsors (1)

Lead Sponsor	Collaborator
Hassan II University

Country where clinical trial is conducted

Morocco, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Postoperative complications	evaluate the complication at 30 days	30 days